CVE-2026-31976

CVE-2026-31976 is a critical-severity vulnerability in Xygeni Xygeni-action with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-506.

Key facts

Description

xygeni-action is the GitHub Action for Xygeni Scanner. On March 3, 2026, an attacker with access to compromised credentials created a series of pull requests (#46, #47, #48) injecting obfuscated shell code into action.yml. The PRs were blocked by branch protection rules and never merged into the main branch. However, the attacker used the compromised GitHub App credentials to move the mutable v5 tag to point at the malicious commit (4bf1d4e19ad81a3e8d4063755ae0f482dd3baf12) from one of the unmerged PRs. This commit remained in the repository's git object store, and any workflow referencing @v5 would fetch and execute it. This is a supply chain compromise via tag poisoning. Any GitHub Actions workflow referencing xygeni/xygeni-action@v5 during the affected window (approximately March 3–10, 2026) executed a C2 implant that granted the attacker arbitrary command execution on the CI runner for up to 180 seconds per workflow run.

Frequently asked questions

What is CVE-2026-31976?
xygeni-action is the GitHub Action for Xygeni Scanner. On March 3, 2026, an attacker with access to compromised credentials created a series of pull requests (#46, #47, #48) injecting obfuscated shell code into action.yml. The PRs were blocked by branch protection rules and never merged into the main branch. However, the attacker used the compromised GitHub App credentials to move the mutable v5 tag to point at the malicious commit (4bf1d4e19ad81a3e8d4063755ae0f482dd3baf12) from one of the unmerged PRs. This commit remained in the repository's git object store, and any workflow referencing @v5 would fetch and execute it. This is a supply chain compromise via tag poisoning. Any GitHub Actions workflow referencing xygeni/xygeni-action@v5 during the affected window (approximately March 3–10, 2026) executed a C2 implant that granted the attacker arbitrary command execution on the CI runner for up to 180 seconds per workflow run.
How severe is CVE-2026-31976?
CVE-2026-31976 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-31976 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (39th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-31976?
CVE-2026-31976 affects Xygeni Xygeni-action. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-31976?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2026-31976 have an EU (EUVD) identifier?
Yes. CVE-2026-31976 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-11331.
When was CVE-2026-31976 published?
CVE-2026-31976 was published on 2026-03-11 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-506 vulnerabilities

Browse all CWE-506 vulnerabilities →